- Home
- IRMD vs CII Comparison
IRMD vs CII Comparison
Compare IRMD & CII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- CII
- Stock Information
- Founded
- IRMD 1992
- CII 2004
- Country
- IRMD United States
- CII United States
- Employees
- IRMD N/A
- CII N/A
- Industry
- IRMD Medical/Dental Instruments
- CII Investment Bankers/Brokers/Service
- Sector
- IRMD Health Care
- CII Finance
- Exchange
- IRMD Nasdaq
- CII Nasdaq
- Market Cap
- IRMD 756.5M
- CII 870.4M
- IPO Year
- IRMD 2014
- CII N/A
- Fundamental
- Price
- IRMD $56.32
- CII $21.36
- Analyst Decision
- IRMD Strong Buy
- CII
- Analyst Count
- IRMD 1
- CII 0
- Target Price
- IRMD $72.00
- CII N/A
- AVG Volume (30 Days)
- IRMD 54.1K
- CII 78.8K
- Earning Date
- IRMD 08-04-2025
- CII 01-01-0001
- Dividend Yield
- IRMD 1.21%
- CII 6.17%
- EPS Growth
- IRMD 10.72
- CII N/A
- EPS
- IRMD 1.55
- CII N/A
- Revenue
- IRMD $75,154,639.00
- CII N/A
- Revenue This Year
- IRMD $10.62
- CII N/A
- Revenue Next Year
- IRMD $9.69
- CII N/A
- P/E Ratio
- IRMD $36.23
- CII N/A
- Revenue Growth
- IRMD 11.04
- CII N/A
- 52 Week Low
- IRMD $42.34
- CII $16.76
- 52 Week High
- IRMD $63.29
- CII $19.81
- Technical
- Relative Strength Index (RSI)
- IRMD 40.34
- CII 64.73
- Support Level
- IRMD $55.77
- CII $21.00
- Resistance Level
- IRMD $57.36
- CII $21.28
- Average True Range (ATR)
- IRMD 1.45
- CII 0.16
- MACD
- IRMD -0.37
- CII -0.04
- Stochastic Oscillator
- IRMD 21.09
- CII 75.00
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.